APA (7th ed.) Citation

Tong, K., Barker, D., France, M., Burr, L., Greville, H., Visser, S., . . . Wark, P. (2020). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis, 19(3), 415. https://doi.org/10.1016/j.jcf.2019.12.006

Chicago Style (17th ed.) Citation

Tong, Koliarne, et al. "Lumacaftor/ivacaftor Reduces Exacerbations in Adults Homozygous for Phe508del Mutation with Severe Lung Disease." Journal of Cystic Fibrosis 19, no. 3 (2020): 415. https://doi.org/10.1016/j.jcf.2019.12.006.

MLA (9th ed.) Citation

Tong, Koliarne, et al. "Lumacaftor/ivacaftor Reduces Exacerbations in Adults Homozygous for Phe508del Mutation with Severe Lung Disease." Journal of Cystic Fibrosis, vol. 19, no. 3, 2020, p. 415, https://doi.org/10.1016/j.jcf.2019.12.006.